Homology Medicines, Inc. (FIXX) Financials

FIXX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 140.1 million 51.9 million
2023-06-30 169.3 million 50.0 million
2023-03-31 197.9 million 46.0 million
2022-12-31 228.5 million 50.5 million

FIXX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -25.3 million 1.7 million
2023-06-30 -23.7 million 2.4 million
2023-03-31 -26.3 million 2.4 million
2022-12-31 -27.2 million 3.1 million

FIXX Net Income

No data available :(

FIXX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 103.3 million - 28.3 million
2023-06-30 127.1 million - 28.7 million
2023-03-31 150.0 million - 29.1 million
2022-12-31 175.0 million - 29.5 million

FIXX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 57.9 million
2023-06-30 57.8 million
2023-03-31 57.7 million
2022-12-31 57.4 million

FIXX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 338000 17.5 million 6.8 million -
2023-06-30 - 23.0 million 8.2 million -
2023-03-31 228000 20.0 million 8.3 million -
2022-12-31 9000 27.1 million 8.1 million -

FIXX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 136000
2023-06-30 354000 564000
2023-03-31 802000 587000
2022-12-31 802000 633000

FIXX

Price: $0.93

52 week price:
0.46
1.76

Earnings Per Share: -2.28 USD

P/E Ratio: -0.31

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 53600

Market Capitalization: 51.9 million

Links: